• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Non-Invasive Cardiac Output Monitoring in Cardiogenic Shock: The NICOM Study
The bioreactance technique is a relatively new, totally noninvasive technique that is used to measure cardiac output (CO) and is easy to use. The Non-Invasive Cardiac Output Monitor (NICOM) is 1 such system. Although approved by the Food and Drug Administration for measurement of stroke volume, there is a paucity of literature validating this technology in decompensated heart failure and cardiogenic shock.
Source: Journal of Cardiac Failure - November 17, 2019 Category: Cardiology Authors: Aniket S. Rali, Tyler Buechler, Bridget Van Gotten, Andrew Waters, Zubair Shah, Nicholas Haglund, Andrew Sauer Tags: Brief Report Source Type: research

Non-Invasive Cardiac Output Monitoring in Cardiogenic Shock – The NICOMTM Study
The bioreactance technique is a relatively new, totally non-invasive technique used to measure cardiac output that is easy to use. Non Invasive Cardiac Output Monitor (NICOM) is one such system (Cheetah Medical Inc). Although approved by FDA for measurement of stroke volume, there is a paucity of literature validating this technology in decompensated heart failure and cardiogenic shock (CS).
Source: Journal of Cardiac Failure - November 17, 2019 Category: Cardiology Authors: Aniket S. Rali, Tyler Buechler, Bridget Van Gotten, Andrew Waters, Zubair Shah, Nicholas Haglund, Andrew Sauer Tags: Brief Report Source Type: research

Obesity Paradox in TAVR: Nationwide Study from 2011-14 Comparing Outcomes of Patients with versus without Obesity Undergoing TAVR
Obesity is associated with several cardiovascular diseases including aortic valve stenosis. Studies have demonstrated a beneficial effect of obesity on patients with cardiovascular disease, deemed the “obesity paradox.” This paradox is also present in obese patients undergoing total aortic valve replacement (TAVR) when examining both short and long-term mortality rates, although the data is conflicting. We aim to investigate the effects of obesity on mortality, length of hospital stay, and ra tes of stroke and cardiogenic shock in patients undergoing TAVR.
Source: Journal of Cardiac Failure - July 31, 2019 Category: Cardiology Authors: Hassaan B. Arshad, Aneil Bhalla, Sara Ayaz Butt, Rehan Umar, Umar Jamshed Sharif Khwaja, Hashim Jilani Tags: 385 Source Type: research

Increased Risk of LVAD Thrombosis in Patients With a Previous History Thromboembolic Event
Heart failure is a clinical syndrome that affects more than 5.1 million Americans and over 23 million individuals worldwide. With the likely substantial growth in the incidence and prevalence of heart failure patients over the next 20-40 years, there will also likely be a corresponding increasein the need for left ventricular assist devices (LVADs). Complications occur and consist primarily of infection, stroke or other thromboembolic event, device malfunction, bleeding, and pump thrombosis. Since LVAD thrombosis can have devastating consequences, including central or peripheral thromboembolism, LVAD malfunction or failure...
Source: Journal of Cardiac Failure - July 31, 2015 Category: Cardiology Authors: Scott Lundgren Tags: Clinical Care I Source Type: research

Thrombolytic Therapy for Thrombosis of Continuous Flow Ventricular Assist Devices
Conclusions: In the setting of LVAD thrombosis, thrombolytic therapy is an alternate treatment strategy in a subset of patients. Candidacy for this alternate procedure must carefully weigh the risks of complications, including hemorrhage and thromboembolism.
Source: Journal of Cardiac Failure - December 19, 2013 Category: Cardiology Authors: Kelly Schlendorf, Chetan B. Patel, Thomas Gehrig, Todd L. Kiefer, G. Michael Felker, Adrian F. Hernandez, Laura J. Blue, Carmelo A. Milano, Joseph G. Rogers Tags: Clinical Investigations Source Type: research